Advanced Imaging Holistic Omics Biobank

Launched by IRCCS SAN RAFFAELE · Jul 25, 2024

Keywords

ClinConnect Summary

The Advanced Imaging Holistic Omics Biobank trial is studying how advanced imaging techniques, like new types of CT and MRI scans, can help us better understand and diagnose serious health conditions such as cancer, neurological disorders, lung diseases, and heart problems. The researchers believe that these scans can reveal hidden information—called "opportunistic features"—that can give insights into a patient's health risks, possibly even more than genetic testing. By collecting and analyzing imaging and clinical data from patients, the trial aims to improve how we screen for diseases and create more accurate predictions about patient outcomes.

To participate in the trial, you must be an adult over 18 years old who is undergoing a CT or MRI scan at the IRCCS San Raffaele Hospital. You’ll need to sign a consent form to allow researchers to collect and use your data. If you agree to join, you will contribute to important research that could lead to better diagnostic tools and treatment approaches in the future. This trial is currently recruiting participants and welcomes individuals of all genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult subjects (\>18 y.o.) submitted to Computed Tomography (CT) using Photon Counting CT scanner (Neaotom Alpha, Siemens) and Magnetic Resonance (MRI) exams acquired with 3T scanner (MR 7700, Philips) for examination required for clinical practice or for clinical trials at the IRCCS San Raffaele Hospital who signe an Informed Consent authorizing data collection.
• Exclusion Criteria:
• • Absent informed consent signed